Quick Info
Status
Currently Recruiting
Estimated Enrollment
12000
Phase
-
Treatment Type
Sample Collection
Trial Type
Observational
Primary Investigator
Bryan J Traynor, M.D.
Contact Information
Locations
National Institute of Aging Clinical Research Unit, Baltimore, 21224
Trial Goal
Tests to Expect
Update Notes
Updated Description & Principal Investigator
1/21/2020
No significant updates.
7/8/2019
No significant updates
4/11/2019
No significant updates
1/30/2019
No significant updates
1/5/2019
No significant updates
12/22/2018
No significant updates
12/8/2018
No significant updates
10/26/2018
No significant updates
8/8/2018
No significant updates
5/4/2018
No significant updates
4/25/2018
No significant updates
4/11/2018
No significant updates
4/4/2018
No significant updates
3/23/2018
No significant updates
1/5/2018
No significant updates
9/29/2017
No significant updates
7/11/2017
No significant updates
4/25/2017
No significant updates
4/20/2017
No significant changes
1/24/2017
No significant updates
1/11/2017
No significant updates
11/10/2016
No significant updates
10/26/2016
Description updated
8/31/2016
Recruitment status/Enrollment criteria updated.
11/17/2015
Protocol updated.
10/20/2015
No significant updates.
8/19/2015
Trial has been suspended.
6/1/2015
Enrollment criteria updated.
5/13/2015
No significant updates.
6/25/2014
No significant updates.
3/18/2014
No significant updates.
2/19/2014
Description updated.
1/7/2014
No significant updates.
12/31/2013
New clinical trial added
12/19/2013

Other Information

Purpose
This study aims to further characterize the genetic basis of movement disorders, including ALS.
Eligibility
Both genders, healthy volunteers accepted, 2 years or older.
Details
There are two basic types of movement disorders. Some cause excessive movement, some cause slowness or lack of movement. Some of these are caused by mutations in genes. On the other hand, dementia is a condition of declining mental abilities, especially memory. Dementia can occur at any age but becomes more frequent with age. Researchers want to study the genes of families with a history of movement disorders or dementia. They hope to find a genetic cause of these disorders. This can help them better understand and treat the diseases. This study will not be limited to a particular disorder, but will study all movement disorders or dementias in general. This study will perform genetic testing to identify the genetic causes of movement disorders and dementia. Today, genetic testing can be done to analyze multiple genes at the same time. This increases the chances of finding the genetic cause of movement disorders and dementias. Objectives: To learn more about movement disorders and dementia, their causes, and treatments.
Collaborator(s)
  • National Institutes of Health Clinical Center (CC) ( National Institute on The first aim of this protocol is to collect families with a history of movement disorder in an attempt to clone the causative gene. The second aim of this protocol isAging (NIA) )
News Articles and Summaries
    -
ALS Forum
-
Trial Protocol as Published on Clinicaltrials.gov
NCT02014246 (First Published: 12/12/2013)